Publication related to RSI or an RSI staff member

Recent oral contraceptive use and adverse birth outcomes.

OBJECTIVE: To examine the possible association between oral contraceptive use and adverse birth outcomes. STUDY DESIGN: We conducted a population-based cohort study of pregnant women who used oral contraceptives within 3 months before their last menstrual period. Subjects were divided into three groups, according to the interval (0-30, 31-60, and 61-90 days) between the dispensing date and their last menstrual period. For each exposed subject, 4 subjects without exposure to oral contraceptives were individually matched by infant’s year of birth and plurality and by mother’s age and parity. RESULTS: Oral contraceptive use within 30 days prior to the last menstrual period was associated with increased risks of very low birth weight (OR: 3.24, 95% CI: 1.18, 8.92), low birth weight (OR: 1.93, 95% CI: 1.17, 3.20), and preterm birth (OR: 1.61, 95% CI: 1.01, 2.55); however, oral contraceptive use 31-90 days prior to the last menstrual period did not increase the risk of low birth weight or preterm birth. CONCLUSION: Our results indicate the use of oral contraceptives near the time of conception may be associated with an increased risk of low birth weight and preterm birth.

Authors

  • Chen, Xi-Kuan, Chen XK, McLaughlin Center for Population Health Risk Assessment, Institute of Population Health, University of Ottawa, Ontario, Canada. xikuan.chen@gmail.com

  • Wen, Shi Wu, Wen SW,

  • Sun, Lu-Ming, Sun LM,

  • Yang, Qiuying, Yang Q,

  • Walker, Mark C, Walker MC,

  • Krewski, Daniel, Krewski D,

YEAR OF PUBLICATION: 2009
SOURCE: Eur J Obstet Gynecol Reprod Biol. 2009 May;144(1):40-3. doi: 10.1016/j.ejogrb.2008.12.016. Epub 2009 Feb 23.
JOURNAL TITLE ABBREVIATION: Eur J Obstet Gynecol Reprod Biol
JOURNAL TITLE: European journal of obstetrics, gynecology, and reproductive biology
ISSN: 1872-7654 (Electronic) 0301-2115 (Linking)
VOLUME: 144
ISSUE: 1
PAGES: 40-3
PLACE OF PUBLICATION: Ireland
ABSTRACT:
OBJECTIVE: To examine the possible association between oral contraceptive use and adverse birth outcomes. STUDY DESIGN: We conducted a population-based cohort study of pregnant women who used oral contraceptives within 3 months before their last menstrual period. Subjects were divided into three groups, according to the interval (0-30, 31-60, and 61-90 days) between the dispensing date and their last menstrual period. For each exposed subject, 4 subjects without exposure to oral contraceptives were individually matched by infant's year of birth and plurality and by mother's age and parity. RESULTS: Oral contraceptive use within 30 days prior to the last menstrual period was associated with increased risks of very low birth weight (OR: 3.24, 95% CI: 1.18, 8.92), low birth weight (OR: 1.93, 95% CI: 1.17, 3.20), and preterm birth (OR: 1.61, 95% CI: 1.01, 2.55); however, oral contraceptive use 31-90 days prior to the last menstrual period did not increase the risk of low birth weight or preterm birth. CONCLUSION: Our results indicate the use of oral contraceptives near the time of conception may be associated with an increased risk of low birth weight and preterm birth.
LANGUAGE: eng
DATE OF PUBLICATION: 2009 May
DATE OF ELECTRONIC PUBLICATION: 20090223
DATE COMPLETED: 20090709
DATE REVISED: 20160803
MESH DATE: 2009/07/10 09:00
EDAT: 2009/02/24 09:00
STATUS: MEDLINE
PUBLICATION STATUS: ppublish
LOCATION IDENTIFIER: 10.1016/j.ejogrb.2008.12.016 [doi]
OWNER: NLM

Related RSI Experts

Daniel Krewski

Chief Risk Scientist

Dr. Daniel Krewski is Chief Risk Scientist and co-founder of Risk Sciences International (RSI), a firm established in 2006 to bring evidence-based, multidisciplinary expertise to the challenge of understanding, managing, and communicating risk. As RSI’s inaugural CEO and long-time scientific...
Read More about Daniel Krewski